Log in to save to my catalogue

Dexpanthenol ameliorates doxorubicin-induced lung injury by regulating endoplasmic reticulum stress...

Dexpanthenol ameliorates doxorubicin-induced lung injury by regulating endoplasmic reticulum stress...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2803331862

Dexpanthenol ameliorates doxorubicin-induced lung injury by regulating endoplasmic reticulum stress and apoptosis

About this item

Full title

Dexpanthenol ameliorates doxorubicin-induced lung injury by regulating endoplasmic reticulum stress and apoptosis

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Naunyn-Schmiedeberg's archives of pharmacology, 2023-08, Vol.396 (8), p.1837-1845

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Doxorubicin (DOX), which is used as a chemotherapeutic agent in the treatment of tumors, has limited use due to its toxicity in various organs and tissues. One of the organs where DOX has a toxic effect is the lung. DOX shows this effect by increasing oxidative stress, inflammation, and apoptosis. Dexpanthenol (DEX), a homologue of pantothenic acid...

Alternative Titles

Full title

Dexpanthenol ameliorates doxorubicin-induced lung injury by regulating endoplasmic reticulum stress and apoptosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2803331862

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2803331862

Other Identifiers

ISSN

0028-1298

E-ISSN

1432-1912

DOI

10.1007/s00210-023-02497-3

How to access this item